NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve management of retinoblastoma (RB). After hearing and assimilating this program, the clinician will be better able to:
1. Predict short- and long-term outcomes of various therapies for RB.
2. Identify RBs that are more likely to be associated with germline mutation and those that are at high risk for metastatic disease.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Ophthalmology
- Start Date: 2022-12-22 06:00:00
- End Date: 2022-12-22 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABO - 1.0 Point; Credit Type(s): Lifelong Learning (ABO)
ABO - 1.0 Point; Credit Type(s): Self-Assessment (ABO) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Oncology
Subscribe
Login
0 Comments
Oldest